Michael Albo retweeted
We have just announced our Q3 2024 financial results and business update.
Join our conference call tomorrow at 8:30 a.m. ET to find out more.
Read our press release:
Michael Albo retweeted
September is #SepsisAwarenessMonth, so we sat down with our CMO, Dr. Andrew Retter, to find out more about our work and #sepsis, what sepsis is, and what difference early sepsis diagnosis would make.
Watch now ⬇️
If our friends @TheStreet (in particular @TheStreetPro) were to hold a 1-2 day conference for subscribers (DFW or Chicago), would you be interested in attending? Speakers could include @ChrisJVersace, @aztecs99, @Sarge986, @hmeisler, @RevShark - just to name a few possibilities.
43%Yes, I'd love to attend
39%Maybe, depends on costs
18%No, I wold not attend
28 votes • Final results Michael Albo retweeted
Our Nu.Q® Vet Cancer Test is now available to veterinarians in Poland through VetLab!
Find out more on their website: tinyurl.com/9d2vbnpd
Michael Albo retweeted
Our Nu.Q® NETs assay detects diseases associated with #NETosis, such as sepsis.
It has the potential to help doctors diagnose disease and could also help predict disease severity, measure the treatment response and monitor disease progression.
More: tinyurl.com/yc4h8h9p
Michael Albo retweeted
Today is #worldveterinaryday - a chance to show our appreciation for the #veterinarians around the world dedicated to ensuring the animals in our lives stay in our lives.
Thank you for everything you do.
Michael Albo retweeted
We are so excited to see our distribution network grow, giving access to our test to more vets, pets, and pet parents with every new collaborator 🐕
Learn more about Nu.Q® Vet on our website: volition.com/nu-q-vet/
Michael Albo retweeted
Today is #WorldCancerDay. Find out how Volition is working with teams at clinical centers of excellence worldwide, undertaking studies to test our technology as an aid for cancer detection, disease progression and treatment response monitoring.
More information: volition.com
Michael Albo retweeted
NEWS: Antech Diagnostics announced they will be launching our breakthrough in-hospital Nu.Q® Vet Canine Cancer test at VMX 2024.
Read their press release for more information: tinyurl.com/325pwfdx
Michael Albo retweeted
DON'T MISS OUT ON OUR SWEET SWEEPSTAKES ! free to enter, chance to win a year or 6 months of all our services. enter here to play. explosiveoptions.net/success…
Have a wonderful vacation @ChrisJVersace!
All of us @TSTAlert members are looking forward to your return.



